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Large-scale human exposure to arsenic
through contaminated groundwater is a seri-
ous health threat in many Asian and Latin
American countries. With the exception of a
series of studies in Taiwan (1–5), attention
has only recently been given to the epidemio-
logical and human toxicological aspects of this
contamination. The tube wells that provide
drinking water in rural Bangladesh are conta-
minated with geologically derived arsenic (6).
Consumption of the contaminated water is a
likely cause of skin conditions such as kerato-
sis and melanosis, which are sensitive manifes-
tations of chronic arsenic toxicity, in many
members of these communities.
In this paper, we describe the dose–
response relationship of chronic arsenic expo-
sure and skin problems in rural Bangladeshi
communities. Two methodologic features
distinguish this investigation from other
recently published reports of the arsenic
problem in Bangladesh and the nearby region
of West Bengal, India (7–13). 
First, the selected indicator of dose/expo-
sure is urinary arsenic concentration ([As]u).
This contrasts with other studies that relied
on the arsenic concentration in the water
from tube wells ([As]tw) (14,15), or indices
derived from it (9,12), as the dose/exposure
indicator. Use of [As]tw or related indices
assumes that water intake across individuals
is similar, or relies on an estimated water
intake. The use of biological dose indicators
is more precise, but has been limited by a
paucity of reports applying such indicators
to the ingestion of arsenic-contaminated
water. Recently, a good correlation between
[As]u and arsenic concentrations in water or
soil was reported for apparently healthy pop-
ulations in the United States (16,17). A
study on the arsenic-exposed population in
West Bengal, India reported on [As]u distri-
bution in the affected population, although a
relationship with arsenic-induced effects was
not reported (8). In addition, a recent study
on a Bangladeshi population used [As]u to
show an elevated risk for arsenicosis in the
subpopulation with the highest quartile
[As]u values (7). The small sample size lim-
ited the signiﬁcance of the study, and an ele-
vated risk was only recognized in the highest
quartile group.
Second, we used a graded scoring of skin
manifestation as the effect indicator. Nearly
all of the preceding studies used a differential
diagnosis approach for defining the end
point. Diagnoses of the features characteristic
of arsenic-induced skin manifestations were
made by experienced personnel in some cases
(9,12) and by consensus diagnostics among
two or more examiners (usually physicians)
in other cases (7,18). These approaches per se
suggest the difficulty of diagnosing arsenic-
induced skin manifestations, which vary
from one person to another in terms of their
severity (19). Instead of relying on such dif-
ferential diagnosis, which generates binary
data, we relied on graded scores based on
physicians’ inspections, regardless of the eti-
ology [i.e., whether caused by arsenic or by
some other agent(s)]. 
Our study using the new methodologies
examined a much larger sample size than the
previous Bangladeshi study (7). We first
evaluated the appropriateness of using [As]u
as a dose/exposure indicator by examining
the dose–response relationship between
[As]u and [As]tw. Then, we examined possi-
ble factors that modify the toxic manifesta-
tions of chronic arsenic exposure. Our study
was reinforced with repeated observations of
the same individuals and used a within-
household male–female comparison to
specifically address the issue of sex-related
differences in susceptibility to arsenic toxic-
ity. In particular, we focused on the effects
of sex, area, and nutritional status (i.e., body
fat), which are possible modulators of arsenic
toxicity (5,7,9,12,18,20). The tube wells in
the subject villages typically supplied drink-
ing water to one or several households.
Although the tube wells were in close prox-
imity, [As]tw showed wide variation,
enabling determination of a dose–response
relationship in a relatively homogenous
environmental setting.
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Spot urine samples were collected from the inhabitants of two rural communities in northwestern
Bangladesh. We compared arsenic levels in the urine samples ([As]u; n = 346) with those in water
from tube wells ([As]tw; range < 1–535 µg/L; n = 86) on an individual basis. The small variation
of [As]u within subjects and highly positive correlation with [As]tw indicate that [As]u is a useful
indicator of exposure. Analyses of [As]u showed that creatinine correction was necessary, that
[As]u only reﬂected recent exposure, and that there were substantial interindividual differences for
a given [As]tw level. To evaluate the toxic effects of arsenic exposure, we constructed a system for
rating skin manifestations, which revealed distinct sex-related differences. Comparison of males
and females in the same households conﬁrmed that skin manifestations were more severe in the
males, and in the males of one community a dose–response relationship between [As]u and the
degree of skin manifestation was evident. The results of this study indicate that [As]u in spot
urine samples can be used as an exposure indicator for As. They suggest that there might be sex-
related, and perhaps community-related, differences in the relationship between [As]u and skin
manifestations, although several confounding factors, including sunlight exposure and smoking
habits, might contribute to the observed sex difference. The existence of such differences should
be further conﬁrmed and examined in other populations to identify the subpopulations sensitive
to chronic arsenic toxicity. Key words: Bangladesh, chronic arsenic toxicity, dose–response rela-
tionship, groundwater contamination, keratosis, melanosis, urinary excretion. Environ Health
Perspect 109:1265–1270 (2001). [Online 28 November 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109p1265-1270watanabe/abstract.htmlMethods
Study areas and populations. The study areas
were two rural communities (SV and SP) in
Sibganji thana (prefecture), Nawabganj dis-
trict, northwestern Bangladesh. The two
communities, each about 1 km2 in area, are 5
km apart.
The inhabitants of these villages subsist
on paddy cultivation and derive some income
from selling mangoes as a cash crop. Their
water supply is entirely dependent on tube
wells that were installed either by house-
holds or by the government. Approximately
100 tube wells, with diverse arsenic concen-
trations, are used for drinking and cooking
purposes.
According to our survey, SV contained
199 households with 933 inhabitants (481
males and 452 females) and SP contained
150 households with 747 inhabitants (405
males and 342 females).
Health examination. A pilot survey was
conducted in November 1998. Urine sam-
ples were collected from a limited number of
people (n = 40; 10 males and 10 females
from each community). The main survey,
conducted in February and March of 1999,
included anthropometric measurements
(height, weight, and four skinfold thick-
nesses: biceps, triceps, subscapular, and
supra-iliac), collection of spot urine samples,
and clinical skin examination by a dermatol-
ogist. Participation by inhabitants visiting
health examination stations was voluntary.
Data were collected from inhabitants who
were at least 20 years of age (112 males and
138 females in SV; 108 males and 193
females in SP). This age group represented a
similar proportion in each community, but
represented more females (approximately
80% of the total adult female population)
than males (approximately 50%).
All the procedures associated with the sur-
vey were approved by the Ethics Committee
of the Graduate School of Medicine, The
University of Tokyo. Written, informed con-
sent was obtained from each participant.
Dermatologic examination and scoring
of symptoms. The two dermatologists who
conducted the dermatologic examinations
were blind to the exposure conditions. They
examined and scored skin manifestations,
evaluating keratosis on the soles of the feet
and palms of the hands and melanosis on the
trunk. Keratosis was defined as skin lesions
with at least five elevated small nodules or
pits. These small nodules or pits were dissem-
inated in the soles or palms bilaterally, having
a cornlike, usually symmetrical shape, with a
mean diameter of about 5 mm. We arbitrar-
ily set a minimum of ﬁve nodules and pits to
exclude small numbers produced by simple
mechanical stimulation (such as walking
barefoot and manual agricultural labor).
Melanosis including hypopigmentation was
identiﬁed as poorly demarcated, mottled areas,
recognizable on most areas of the abdomen
and back, which are relatively unexposed to
sunlight. Melanosis can be distinguished from
melanoma by its relatively homogeneous size
and shape and its multiple occurrence.
Keratosis on the sole was scored from 0 (nor-
mal) to 4 (most severe), and that on the palm
was scored from 0 to 3. Melanosis on the
trunk was scored from 0 to 2. More details of
the dermatologic findings will be reported
elsewhere (21). Assuming that early manifesta-
tions of poisoning are more frequent than
advanced manifestations, the resulting possible
score of 9 for positive manifestations (4 + 3 +
2 for sole, palm, and trunk, respectively) was
integrated into a single effect indicator called
the dermatologic stage (DS; Table 1).
To determine the DS, we first ranked
each of these manifestations in order of
decreasing prevalence. Thus, the most preva-
lent manifestation was ranked 1 and the
rarest ranked 9; skin of normal appearance
was given a rank of 0. Prevalence was cumu-
lative: if a person had a sole keratosis score of
3, then he/she was counted as positive for
scores 1 and 2 as well. The highest rank of
the sole, palm, and trunk scores was the
individual’s overall rank. The nine ranks
were then collapsed into ﬁve stages, and the
stage corresponding to the individual’s rank
was defined as his or her DS. The scoring
was irrespective of the etiology (related to
arsenic or not), with three exceptions.
Calluses visually identiﬁed as resulting from
physical labor and hereditary keratoderma or
Darier’s disease, identiﬁed by visual inspec-
tion and family history, were excluded.
Tube well survey. Water samples were
collected from all the tube wells (n = 101) in
SV and SP. Of these, 88 tube wells (32 in
SV, 56 in SP) were used for drinking and
cooking by the subjects of this study. Freshly
pumped water was collected after at least 10
strokes of a hand pump. Each water sample
was immediately acidiﬁed by adding HCl to
a ﬁnal concentration of 1% (v/v) to prevent
the precipitation of an iron complex that
absorbs arsenic (11). At the time of water
collection, the local health staff interviewed
the residents to identify the depth and age of
each tube well and the users of the well. The
ages of the tube wells ranged from < 1 year
to 30 years (median: 6 years). 
Both the acidified water and the urine
samples were kept frozen until they were
taken to the laboratory in Japan, where they
were kept at –80oC until the assay.
Arsenic determination. The total arsenic
concentrations of the tube well water
([As]tw) and urine samples ([As]u) were
determined by an atomic absorption spec-
trometer equipped with a flow injection
hydride generator (HGAAS; ZL-4100,
Perkin Elmer, Norwalk, CT, USA ). The
urine samples were ﬁrst wet-ashed by heating
with a mixture of nitric, perchloric, and sul-
furic acids. Then both the water and the
ashed urine samples were pre-reduced by
potassium iodide in the acidified solution.
Arsenic determination followed.
The detection limits (DLs) of the
HGAAS were 1 and 3 µg/L in the water and
urine samples, respectively. All of the urine
samples produced values above the DL.
Those water samples for which readings were
below the DL were assigned a value of one-
half the DL (0.5 µg/L).
Assay accuracy was ensured by the inclu-
sion of reference materials: NIST 1643d
(trace metal in water; National Institute of
Standards and Technology, Gaithersburg,
MD, USA) and NIES #18 (human urine;
National Institute for Environmental
Studies, Tsukuba, Japan) (22). The obtained
values fell within the certiﬁed ranges (56.02
± 0.73 µg/L for NIST 1643d, and 0.137 ±
0.011 mg/L for NIES #18). For the spot
urine samples, the creatinine concentration
was also determined spectrophotometrically
using a commercial kit (Creatinine Wako,
Wako Pure Pharmaceuticals, Osaka, Japan),
based on the Jaffe’s reaction (23).
Exposure indicators. [As]tw and [As]u were
used as indicators of exposure to inorganic
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Table 1. Classiﬁcation criteria of DS and distribution of subjects by DS.
Criteria for the stagea Frequency distributionb
DS Rank Manifestation Prevalence [%]c No. (total = 468) Percent of total
0 None 213 45.5
11 Sole 1 53.8 148 31.6
22 Sole 2 18.4 37 7.9
33 Palm 1 9.8 43 9.2
4 Trunk 1 8.3
45 Sole 3 5.1 19 4.1
6 Palm 2 3.4
5 7.5 Sole 4 1.1 8 1.7
7.5 Trunk 2 1.1
9 Palm 3 0.6
aFor an individual diagnosed as sole = 3, palm = 2, trunk = 1, the corresponding ranks are 5, 6, and 4, respectively; the DS
corresponding to the highest of these three ranks (6), which is 4, is assigned as this individual’s DS (see text for details).
bActual distribution of the subjects classiﬁed for each DS. cPrevalence of the manifestation.arsenic. Unless otherwise described, the [As]u
was adjusted for creatinine (i.e., µg/g creati-
nine). Because the study population subsisted
mainly on local produce and rarely consumed
saltwater ﬁsh or other seafood, the contribu-
tion of these arsenic-rich foods to [As]u was
assumed to be negligible. This notion was
supported by a preliminary analysis using
HPLC-inductively coupled plasma-mass spec-
trometry (kindly performed by Y. Shibata,
National Institute for Environmental Studies,
Tsukuba, Japan; data not shown). A peak cor-
responding to arsenobetaine, an organic form
of arsenic commonly found in seafood, was
absent from all 20 urine samples randomly
selected from the study population; concur-
rently analyzed urine samples obtained from
Japanese volunteers contained arsenobetaine.
Statistical analyses. Subjects were divided
into four subgroups by sex and area (SP or
SV). For [As]tw, [As]u, and percent body fat,
a log-transformation was applied to normal-
ize the distribution. In these cases, geometric
mean and SD are shown. Between-group
differences were tested by analysis of vari-
ance (ANOVA) or analysis of covariance
(ANCOVA) using a JMP software program
(version 4.0; SAS Institute, Cary, NC,
USA). The associations between the expo-
sure indicators, [As]tw and [As]u, and the
effect indicator, DS, were evaluated using
the log-likelihood chi-square test. Unless
otherwise specified, p-values < 0.05 were
considered statistically signiﬁcant.
Results
Tube well and urinary arsenic. The arsenic
exposure indices, along with several basic
characteristics of the subpopulations, are
shown in Table 2. All of the subgroups had
similar mean ages, and the expected sex dif-
ferences for height, weight, and percent
body fat were apparent. Twenty-eight per-
cent of SP and 39% of SV subjects used tube
wells in which [As]tw exceeded 50 µg/L, the
regulatory upper limit for drinking water in
Bangladesh. The mean [As]tw differed signif-
icantly between SV and SP, although the
ranges were almost identical (SV, < 1–535
µg/L; SP, < 1–519 µg/L). The [As]u varied
considerably among the subjects, ranging
from 42 to 2,017 µg As/g creatinine in SV
and from 24 to 3,398 µg As/g creatinine in
SP. Signiﬁcant area differences and marginal
sex differences were evident for [As]u, with
females having higher levels than males.
Within-subject chronologic variation of
[As]u was assessed in 21 individuals by col-
lecting samples in November 1998 and
February 1999 (Figure 1). Excluding two
individuals described subsequently, the over-
all correlation of two [As]u was 0.89 (n = 19;
p < 0.001), and the mean of the second [As]u
was 106 ± 53% of the ﬁrst, ranging between
56 and 265%. Two of the 21 individuals
made a new tube well immediately after the
first survey, due to the high level of [As]tw
found in the old tube well. Their [As]u
declined rapidly, to 27% and 18% of their
ﬁrst [As]u readings, respectively.
Relationship between [As]tw and [As]u.
Highly significant correlations (R2 = 0.504;
p < 0.001) were found between [As]tw and
[As]u for the entire population (Figure 2)
and for each of the four subgroups.
ANCOVA, taking [As]tw as the covariate,
showed that the effect of sex, where females
had a higher [As]u than males, was signifi-
cant (p < 0.005) after adjusting for [As]tw,
but the effect of area was not.
In the stepwise multiple regression analy-
ses for [As]u, [As]tw was selected with high
significance in all the groups (Table 3).
Although the age and percent body fat were
signiﬁcant or marginally signiﬁcant in some
cases, the observation did not suggest a pat-
tern that was consistent across the subgroups.
When both areas were combined, [As]tw, age,
and percent body fat were all selected as sig-
niﬁcant variables in males (both age and per-
cent body fat were negative coefficients),
while [As]tw and percent body fat (with a
negative coefﬁcient) were selected in females
(data not shown).
Dose–response relationship between expo-
sure indicators and skin manifestations. To
examine the relationship between the expo-
sure indicators and the effect indicator, DS,
we divided the whole population into tertiles
either by [As]u or [As]tw values and compared
the frequency distributions of the DS in each
tertile group (Figure 3). The [As]u values of
the lower, middle, and upper tertile groups
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Table 2. Age, nutritional status, and arsenic exposure in the groups divided by sex and by area.
Age Height Body weight Percent [As]tw
b [As]u
Area, sex (years) (cm) (kg) body fata (µg/L) (µg/g creatinine)
SV
Male 36 (1.5) 162 (5) 52 (7) 10.7 (1.4) 28 (6.0) 204 (2.1)
(n = 112) (n = 111) (n = 111) (n = 111) (n = 104) (n = 64)
Female 36 (1.4) 151 (6) 43 (6) 21.4 (1.2) 26 (6.6) 219 (2.4)
(n = 138) (n = 137) (n = 138) (n = 137) (n = 126) (n = 108)
SP
Male 40 (1.5) 164 (6) 51 (7) 10.7 (1.5) 11 (6.6) 126 (2.3)
(n = 108) (n = 107) (n = 100) (n = 108) (n = 108) (n = 69)
Female 35 (1.5) 152 (5) 44 (7) 20.9 (1.3) 10 (6.4) 174 (2.5)
(n = 193) (n = 192) (n = 162) (n = 192) (n = 189) (n = 121)
ANOVAc 
Area NS # NS NS ** **
Sex # ** ** ** NS #
Area × sex # NS NS NS NS NS
NS, not signiﬁcant (p > 0.1). Values shown are geometric mean (SD). 
aCalculated from skinfold thickness. bThe arithmetic means ± SDs were 88 ± 13, 85 ± 12, 58 ± 12, and 48 ± 8 µg/L for SV
males, SV females, SP males, and SP females, respectively. cTwo-way ANOVA using log-transformed variables. **p <
0.001; #0.05 < p < 0.1.
Figure 1. Comparison of [As]u values obtained
from the same individuals at an interval of approx-
imately 3 months. [As]u values measured on
February 1999 are plotted against those measured
on November 1998 (logarithmic scale). Each circle
denotes one individual. The two yellow circles are
individuals who showed a rapid decrease in [As]u
after switching from high-As tube wells to low-As
tube wells after the first sampling (November
1998) (see text). The straight line indicates x = y.
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Figure 2. Relationship between [As]u and [As]tw.
Each circle denotes one individual, and the lines
are the regression lines for each subpopulation.
Females had a significantly higher [As]u than
males, after correcting for [As]tw (by ANCOVA;
see text). Note that the two dotted lines for
females are higher than the two lines for males.
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SP femalesranged from 24 to 110 (median = 76; n =
121), 111 to 235 (median = 155; n = 120),
and 239 to 3,398 (median = 402; n = 121)
µg/g creatinine, respectively. The correspond-
ing [As]tw values ranged from 0.5 to 126
(median = 4), 0.5 to 519 (median = 11), and
0.5 to 535 (median = 88) µg/L for the respec-
tive groups. For each group defined by sex
and village, these three tertile groups did not
differ in age and percent body fat, except for
the SP females, in which the lower tertile had
a higher percent body fat. In the SV males,
the [As]u tertile populations had different DS
distributions from each other: the higher
[As]u tertile groups had a greater proportion
of individuals with a high DS (Figure 3A; χ2
= 20.87; p<0.05 by likelihood ratio test; also
see Figure 3C). Neither the SV females
(Figure 3B; also see Figure 3D) nor the SP
male–female groups (data not shown) showed
this dose–response relationship. No such asso-
ciation was evident when the [As]tw tertiles
replaced the [As]u tertiles (data not shown).
Although the levels of exposure were
similar between the sexes, overall DS was
higher in males than in females, and the DS
of the two sexes were statistically different by
a median test (p < 0.005).
Male–female comparison within the same
households. To further conﬁrm the possible
sex difference in the manifestation of chronic
arsenic toxicity noted above, we analyzed the
[As]u values of male–female pairs from the
same household who shared the same tube
well. To avoid a possible confounding effect
of age, we included in this analysis only
male–female pairs whose age difference did
not exceed 20 years. Of the 68 pairs (44 from
SP and 24 from SV) who ﬁt the criteria, [As]u
values were highly correlated with the part-
ner’s [As]u (R2 = 0.74; p<0.001; Figure 4). In
most cases, the female’s [As]u exceeded that of
the male partner, and the male–female differ-
ence was signiﬁcant (p < 0.01, paired t-test).
On the other hand, males exceeded females in
terms of DS in most couples, and the differ-
ence was signiﬁcant (p < 0.001; paired t-test;
data not shown).
Discussion
In this study we evaluated exposure to
arsenic and manifestations of arsenic toxic-
ity. To our knowledge, this is the ﬁrst report
to show a sex difference in the dose–response
relationship with respect to [As]u. Before
exploring this point, we discuss the nature of
[As]u as a dose indicator. 
Urinary arsenic as a dose indicator. The
study revealed the usefulness, and some limi-
tations, of [As]u as an exposure indicator.
Two observations that strongly support the
use of [As]u as an exposure indicator in
nonoccupational, chronic exposure to
arsenic are the relatively small within-subject
variation of [As]u, which is consistent with
previous reports on nonoccupational popula-
tions (16,17), and the reasonable correlation
with [As]tw for all four subgroups, as well as
for male–female pairs using the same tube
well. The latter observation implies that
extra water intake of arsenic is negligible or
constant across individuals, which will be
discussed later. [As]u is especially valuable as
an exposure indicator because spot urine is
relatively easy to collect and transport, and it
provides an objective measure of exposure.
In our samples, [As]u (corrected for crea-
tinine) was judged a better indicator than the
uncorrected urinary arsenic concentration.
Without this adjustment, the correlation
between urinary arsenic and [As]tw and the
within-household and intraindividual corre-
lations of urinary arsenic, all of which are
biologically reasonable correlations, were less
remarkable (data not shown). Moreover, the
partial correlation between uncorrected [As]u
and creatinine was highly significant, even
after being corrected for [As]tw, while the
partial correlation between the corrected
[As]u and creatinine was not signiﬁcant. Only
6.4 % (23/362) of the urine samples used for
the analyses had a creatinine concentration
< 0.3 g/L, while none exceeded 3.0 g/L, and
exclusion of these samples did not change the
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Table 3. Stepwise multiple regression analyses of urinary arsenic excretion (parameter estimate and its
signiﬁcance).
Adjusted Percent 
Area, sex R2 Intercept [As]tw Age body fat
SV
Male 0.47 3.486** 0.294** –0.293a,#
Female 0.43 2.839** 0.320**
SP
Male 0.64 3.515** 0.356** –0.237#
Female 0.51 3.482** 0.328** –0.440*
aA blank indicates that the parameter was not selected (entered) as a signiﬁcant independent variable in the regression
model. **p < 0.001; *p < 0.05; #0.05 < p < 0.1.
Figure 3. Dose–response relationship at different levels of [As]u in the SV male and female populations. Male
(A) or female (B) subjects were divided into three tertile groups by the [As]u values, showing the relative fre-
quency distribution of the positive DS, ranging from 1 (mild) to 5 (most severe), for each tertile group. For
males, the distribution pattern differs among the tertiles (log-likelihood chi-square test; p < 0.05). In the abs-
icca, median and range (in parentheses; µg/g creatinine ) of the [As]u for each tertile group are shown. The
DS of each male (C) or female (D) individual was plotted against his/her [As]u. The regression line is arbitrary
because the DS is a discrete variable. 
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5overall results of the analyses except for the
weakened correlations described above. It
should be noted, however, that two previous
studies examined morning ﬁrst-voided urine
samples, and both found that creatinine
adjustment did not improve the correlation
between urinary and environmental arsenic
levels (17,24). The time of sampling, and
therefore the extent of hydration, would be
more homogenous in these previous studies
than in our study, which may explain the
discrepancy.
Urinary arsenic likely reﬂects only recent
exposure to arsenic. The two individuals who
changed their tube well between the ﬁrst and
second monitoring events showed drastic
changes in [As]u over the 3-month period.
The high correlation between the current
[As]u and [As]tw per se may also be evidence
of this phenomenon. Excretion of ingested
inorganic arsenic is rapid: more than half of
an ingested dose was excreted within 2 days
in human experiments (25–27). Therefore, it
is conceivable that [As]u reﬂects recent (up to
1 week) exposure. It should be noted, how-
ever, that [As]u may also reﬂect past exposure
in field situations where there has been
chronic exposure (months or years) to
arsenic; 2 months after the cessation (sub-
stantial reduction) of arsenic exposure via
drinking water in a Chilean population, [As]u
remained somewhat higher than the level
expected from [As]tw (24). The release of
arsenic from internal deposits from past
exposure at higher levels was thought to be
among the possible mechanisms explaining
this observation (24).
Another noteworthy feature is the large
interindividual variation of [As]u, by as
much as 10-fold, among individuals sharing
the same [As]tw levels, despite a good correla-
tion between [As]u and [As]tw for the entire
population (or each subpopulation). Visual
inspection of the data did not suggest that
sex, age, or percent body fat could ade-
quately explain the variation. Within-indi-
vidual, day-to-day variation was within a
3-fold range (56–265%; Figure 1) and did
not appear to account for the difference.
Interindividual differences in arsenic intake
from sources other than their regular tube
well (including food or water from other
tube wells) might be a factor in accounting
for such variation in [As]u. A visual inspec-
tion of the regression line (Figure 2) shows
that in the lower [As]tw range (up to ~100
µg/L), [As]u was much higher than [As]tw,
suggesting such extra sources of arsenic.
Alternatively, some environmental, nutri-
tional (e.g., a minor nutrient such as sele-
nium), or genetic factors may modify the
toxicokinetics of ingested arsenic. Another
possible source of the variation between
individuals is variation in past exposure, as
discussed above. These possible reasons for
interindividual variation in [As]u should be
tested in future research. A similar range of
interindividual variation was reported in a
previous study in Bangladesh, which specu-
lated that the differences were due to varia-
tion in arsenic metabolism between
individuals (7). In this context, it bears men-
tioning that many preceding studies found
arsenicosis among the groups consuming the
lowest levels of [As]tw, which was specula-
tively ascribed to the putative existence of
susceptible subgroups (7,9,12). The present
results suggest that such differences may
have their origins in the kinetics/intake of
arsenic, rather than in susceptibility.
Sex differences in the dose–response rela-
tionship. The [As]u values for females were
higher than those for males. After correcting
for [As]tw, the difference was significant.
This sex-related difference is probably at
least partly due to the creatinine adjustment
of the arsenic concentration, by which excre-
tion in females is overestimated relative to
that in males (28). However, because this
would result in an overestimation of 10% at
most (28), correcting for this factor would
reduce or negate the sex-related difference,
but never reverse it. Thus, it is unlikely that
the exposure level of males exceeded that of
females in this population.
In view of the relatively homogenous
relationship between [As]tw and [As]u, the
distinct differences in the dose–response
relationship among subpopulations are note-
worthy. The signiﬁcantly higher median DS
in males supports the existence of a sex differ-
ence in the dose–response relationship, and
the within-household analysis further sup-
ports this idea. Relative hyperresponsiveness
in males with regard to [As]tw has been
described previously (5,9,12), but other
studies did not ﬁnd any sex differences, per-
haps partly because of small sample sizes
(5,7). No study has reported a female hyper-
response. Because the [As]u levels were either
similar between the sexes or were even higher
in females, such a sex difference might suggest
that males have a higher susceptibility to a
given amount of arsenic. Furthermore, the
relationship between [As]u and the rank of
each anatomic location (sole, palm, and
trunk) showed similar sex-related differences,
as males were more susceptible, although sta-
tistical significance was not always found
(data not shown). More detailed descriptions
of sex-differences in the skin manifestations of
arsenic toxicity are presented elsewhere (21).
There are several alternative interpreta-
tions that might argue against higher suscepti-
bility in males. First, the differential coverage
rate between sexes (80% of females vs. 50%
of males) could have introduced a bias if the
males who participated were the males most
affected. The within-household comparisons
argue against this possibility, as the coverage
rate was intrinsically the same. Second, even
though the [As]u levels were similar between
the sexes, cumulative exposure may have been
much higher in males, who were mostly born
in this area, than in females, who mostly
migrated from less contaminated areas
nearby. The use of tube wells in SV and SP
started approximately 20 years ago, at most.
Assuming the mean in-migration of females
upon marriage occurred at around the age of
20 years, male–female pairs in which the
woman is now more than 40 years old would
have similar exposure periods. However, even
when only such couples were selected, the
between-sex difference remained significant
when their DS values were compared.
Therefore, a sex difference does appear to
exist, although the mechanisms that account
for the difference are not clear. 
Two other potentially confounding fac-
tors, sunlight exposure and smoking, may
account for the observed sex-related differ-
ence in the dose–response relationship.
Exposure to sunlight is associated with der-
matologic conditions such as melanosis and
keratosis (29). If such changes are imposed
on arsenic-induced skin lesions, then males,
being more likely to be exposed to sunlight
than females (due to farming activities), may
have more severe skin manifestations.
However, such a facilitating effect of sun-
light is usually conﬁned to sunlight-exposed
areas of skin, while the sole of the foot and,
to a lesser extent, the palm of the hand,
where the skin lesions were diagnosed, are
two of the least sun-exposed sites on the
body, and melanosis was also prominent in
unexposed areas of the trunk. Therefore, it
appears unlikely that sunlight had a substan-
tial effect on the skin manifestations
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Figure 4. Comparison of [As]u between males and
females. Each circle denotes a couple who
shared a tube well. The correlation was highly
signiﬁcant for both areas. The regression line for
SP is female [As]u = 0.188 ± 0.950 (male [As]u; r =
0.88), and for SV is female [As]u = 0.105 ± 0.987
(male [As]u; r = 0.83). Both lines were statistically
signiﬁcant (p < 0.001). 
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Males [As]uobserved, although this factor should not be
neglected. The contribution of smoking to
the observed sex difference is currently
unknown, although smoking was rarely
observed, even among males, because most
of the subjects in the study area were
Muslims, who tend to refrain from smoking.
Finally, it should be added that despite
the similar environment and lifestyle shared
by the two communities, the dose–response
relationship was apparent only in the SV
males. This could be a chance finding.
Alternately, an unidentified environmental
factor (such as minor nutrients) or genetic
factors may lead to such a difference.
Elucidation of such modifying factors should
be of great importance in the future imple-
mentation of any mitigation or intervention
measures. This requires further investigations
of human populations.
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